Creative Biolabs was established in 2004 by scientists who are dedicated to conquering of cancer. Over the past 10 years, Creative Biolabs has grown into a recognized world leader in antibody (rAb) discovery, engineering, production, and analysis. Standing on the shoulder of a giant, our bispecific antibody (BsAb) team has a collective of experienced scientists committed to providing high-quality service to customers all over the world.
Creative Biolabs has been dedicated to the development of our techniques. Now, with the cutting-edge platforms and methods (quadroma development, chemical conjugation, and genetic engineering), a comprehensive list of bispecific antibody products is available to customers in academia and industry fields. According to modular architecture, Creative Biolabs is experienced in producing five major groups of bispecific molecules: bispecific IgGs, appended IgGs, BsAb fragments, bispecific fusion proteins and BsAb conjugates. In addition, our platforms make us the best choice for production of innovative customized designs. With novel strategies and proprietary Creative Discovery Platform™, Creative Biolabs can always adjust the design of the product to meet client’s requirements on format, valency, flexibility and half-life of the BsAb.